Abstract
Formulations were prepared containing Bergenia ligulata, Didymocarpus pedicellata, Dolichos biflorus, Boerhaavia diffusa, Crataeva nurvala and Ocimum sanctum in different ratios and coded as F1, F2 and F3. In vivo urolithiatic activities of the prepared formulations (i.e. F1:20, F1:40, F1:60, F2:20, F2:40, F2:60, F3:20, F3:40 and F3:60) were performed in rats using ethylene glycol induced urolithiasis model. It was observed that in comparison with the standard drug i.e. Cystone (30 mg/kg b wt.) the prepared formulation F3:60 (60 mg/kg b wt.) have shown significant antilithiatic activity.
Keywords: Urolithiasis, herbal formulation, Bergenia ligulata, Didymocarpus pedicellata, Dolichos biflorus, Boerhaavia diffusa, Crataeva nurvala, Ocimum sanctum.
Graphical Abstract
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Drug Safety
Current Drug Targets
Current Organic Chemistry
Current Organic Synthesis
Mini-Reviews in Organic Chemistry
Letters in Organic Chemistry
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Related Books
Advances in Organic Synthesis
Frontiers in Drug Design and Discovery
The Synthetic Methods, Structures, and Properties of the Ca-C σ Bond Organocalcium Containing Compounds
Advances in Organic Synthesis
Chemistry of Bipyrazoles: Synthesis and Applications
Frontiers in Cardiovascular Drug Discovery
Advances in Organic Synthesis
Advanced Nanocatalysis for Organic Synthesis and Electroanalysis
Frontiers in Drug Design and Discovery
Advances in Organic Synthesis
25
2
1
1